Showing results (581-590 of 611) with videos related to

Sort By:
Pageof 62
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
The Journal of Clinical Investigation|August 15, 2023
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Cell|January 12, 2022
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage nichesMartin Guilliams, Johnny Bonnardel, Birthe Haest, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Pageof 62